Overview / Abstract: |
This immersive CME infographic will provide a stepwise visual to support improved recognition and management of rare immune-related adverse events (irAEs) for patients on immune checkpoint inhibitors (ICPIs). The infographic will synthesize and visualize data, guidelines and decision-making recommendations, as well as imbed faculty commentaries that offer “how-to” methods for introducing strategies and practical resources that support personalized therapeutic management. This activity is intended for oncologists, hematologists, gastroenterologists, cardiologists, internists, emergency medicine physicians and other specialists who care for oncology patients receiving immune checkpoint inhibitors. Upon completion of this activity, participants will be able to: |
Expiration |
Jul 10, 2021 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME, Radiology / RAD Tech CE, Respiratory Therapy CE |
Format |
Online, Webinar / Webcast / Video |
Credits / Hours |
1.0 |
Accreditation |
ACCME, CBRN |
Presenters / Authors / Faculty |
John A. Thompson, MD Marianne Davies, DNP, MSN, RN, APRN, CNS-BC, ACNP-BC, AOCNP |
Activity Specialities / Related Topics |
Adverse Drug Reactions / ADR, Cardiology / Cardiovascular, Education / Teaching, Emergency Medicine, Endocrinology, Hematology, Immunology / Immunosuppression, Neurology, Oncology / Cancer / Radiation Therapy, Pulmonary Medicine / COPD |
Sponsors / Supporters / Grant Providers |
Supported by an educational grant from Bristol Myers Squibb. |
Keywords / Search Terms |
ACHL Immune checkpoint inhibitors, ICPIs, adverse events, anti–CTLA-4, ipilimumab, YERVOY, anti PD-1 antibody, nivolumab, OPDIVO, pembrolizumab, anti-PD-L1 antibody, atezolizumab, durvalumab, avelumab, pneumonitis, myocarditis, BMS, CME, infographic, Brahmer, Davies, medical education, ASCO, NCCN, EULAR, oncology, hematology, irAEs, irAE, AEs, IO agents, immunooncology, rare irAEs Free CE CME |